A novel redox mechanism for the glutathione-dependent reversible uptake of a fungal toxin in cells

被引:80
作者
Bernardo, PH
Brasch, N
Chai, CLL
Waring, P [1 ]
机构
[1] Australian Natl Univ, The Faculties, Ctr Study Bioact Mol, Canberra, ACT 0200, Australia
[2] Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia
关键词
D O I
10.1074/jbc.M304825200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The fungal metabolite gliotoxin is characterized by an internal disulfide bridge and can exist in either disulfide or dithiol forms. Gliotoxin and other members of the epipolythiodioxopiperazine class of toxins have immunosuppressive properties and have been implicated in human and animal mycotoxicoses. The bridged disulfide moiety is thought to be generally essential for biological activity. Here we show that only the natural ( oxidized) form of gliotoxin is actively concentrated in a cell line in a glutathione- dependent manner. Intracellular levels of the toxin can be up to 1500- fold greater than the applied concentration, and toxin in the cells exists almost exclusively in the reduced form. A simple model of toxin entry followed by reduction to the cell- impermeant dithiol explains active uptake, cell density dependence of EC50 values and predicts a value for the maximum concentration of toxin at limiting cell density in agreement with the experiment. Oxidation of the intracellular toxin results in rapid efflux from the cell that also occurs when glutathione levels fall following induction of apoptotic cell death by the toxin. This mechanism allows for minimal production of the toxin while enabling maximal intracellular concentration and thus maximal efficacy of killing in a competitor organism initially present at low cell density. The toxin effluxes from the apoptotic cell exclusively in the oxidized form and can further enter and kill neighboring cells, thus acting in a pseudocatalytic way.
引用
收藏
页码:46549 / 46555
页数:7
相关论文
共 37 条
[1]  
BEAVER JP, 1995, EUR J CELL BIOL, V68, P47
[2]   Evidence for gliotoxin-glutathione conjugate adducts [J].
Bernardo, PH ;
Chai, CLL ;
Deeble, GJ ;
Liu, XM ;
Waring, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (04) :483-485
[3]   The structure and function of drug pumps [J].
Borges-Walmsley, MI ;
Walmsley, AR .
TRENDS IN MICROBIOLOGY, 2001, 9 (02) :71-79
[4]   Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1 [J].
Brodin, B ;
Nielsen, CU ;
Steffansen, B ;
Frokjær, S .
PHARMACOLOGY & TOXICOLOGY, 2002, 90 (06) :285-296
[5]   Redox sensitive epidithiodioxopiperazines in biological mechanisms of toxicity [J].
Chai, CLL ;
Waring, P .
REDOX REPORT, 2000, 5 (05) :257-264
[6]  
Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1
[7]   Pharmaceutically active secondary metabolites of microorganisms [J].
Demain, AL .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 1999, 52 (04) :455-463
[8]  
EICHNER RD, 1988, J BIOL CHEM, V263, P3772
[9]   THE EFFECT OF GLIOTOXIN UPON MACROPHAGE FUNCTION [J].
EICHNER, RD ;
ALSALAMI, M ;
WOOD, PR ;
MULLBACHER, A .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1986, 8 (07) :789-797
[10]  
EICHNER RD, 1984, AUST J EXP BIOL MED, V82, P479